Pfizer stock holds near USD 28 as earnings date approaches

Published on 09/22/2026 at 11:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock traded at USD 27.75 on September 21, 2026, below its USD 29.21 yearly high. August EPS reached USD 0.77, beating estimates by USD 0.09.

Fotorealistische unbeschriftete Pharma-Anlage bei Dämmerung, Symbolbild für Pfizer Inc — Fotorealistische Pharma-Produktionsanlage bei Dämmerung symbolisiert Pfizer Inc. mit ISIN US7170811035 im Biotech-Sektor, Illustration mit AI erstellt.

Pfizer Inc. (ISIN US7170811035) traded at USD 27.75 on the NYSE on September 21, 2026, with the share price 0.6 percent below that session's high of USD 27.92. The stock remains below its 52-week high of USD 29.21 and above its 52-week low of USD 23.58, giving investors a defined range ahead of the next earnings date.

Next report is dated November 3

According to Zacks on September 21, 2026, Pfizer's next earnings release is expected on November 3, 2026. The consensus estimate for the quarter ending September 2026 is USD 0.79 per share, which sets the next measurable test for the company.

Pfizer's most recently reported quarter ended in June 2026. MarketBeat reported on September 22, 2026, that Pfizer delivered quarterly EPS of USD 0.77, exceeding the consensus estimate of USD 0.68 by USD 0.09. Revenue increased 2.6 percent year over year in that quarter.

Income appeal meets valuation limits

The earnings comparison is positive, but the forward hurdle is visible: the September 2026 consensus of USD 0.79 is USD 0.02 above the latest reported EPS of USD 0.77. Seeking Alpha wrote on September 21, 2026, that Pfizer's non-COVID portfolio was growing 5 percent operationally and that pipeline activity stood USD 1.5 billion ahead of the original 2026 base-business guidance.

Market data also show a divided valuation picture. StockAnalysis listed an average analyst price target of USD 28.88 and a consensus rating of Buy on September 22, 2026, while MarketBeat showed a USD 28.39 consensus target and a Hold rating. The gap between those two aggregates is USD 0.49, so the November report remains more important than a broad label alone.

Pfizer stock stays below yearly high

Pfizer stock closed at USD 27.75 on the NYSE on September 21, 2026. The same market snapshot showed a market capitalization of USD 158.11 billion and volume of 27.92 million shares, compared with average daily volume of 33.87 million.